We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for risdiplam (Roche Products Pty Limited)
Active ingredients
risdiplam
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for oral solution
Indication
For the treatment of Spinal Muscular Atrophy (SMA)
Therapeutic area
Neurology